| __timestamp | Supernus Pharmaceuticals, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 5758000 | 2395000 |
| Thursday, January 1, 2015 | 8423000 | 9057000 |
| Friday, January 1, 2016 | 11986000 | 393000 |
| Sunday, January 1, 2017 | 15215000 | 79309000 |
| Monday, January 1, 2018 | 15356000 | 134428000 |
| Tuesday, January 1, 2019 | 16660000 | 175431000 |
| Wednesday, January 1, 2020 | 52459000 | 124165000 |
| Friday, January 1, 2021 | 75061000 | 121875000 |
| Saturday, January 1, 2022 | 87221000 | 10114000 |
| Sunday, January 1, 2023 | 83779000 | 9206000 |
In pursuit of knowledge
In the competitive world of biotechnology, cost efficiency can be a decisive factor for success. Supernus Pharmaceuticals, Inc. and Wave Life Sciences Ltd. have shown contrasting trends in their cost of revenue from 2014 to 2023. Supernus Pharmaceuticals started with a modest cost of revenue, peaking in 2022 with a 1,414% increase from 2014. Meanwhile, Wave Life Sciences experienced a dramatic rise, reaching its zenith in 2019 with a staggering 7,225% increase from its 2014 baseline. However, by 2023, both companies saw a decline, with Supernus reducing costs by 4% from its peak, while Wave Life Sciences saw a significant 95% drop from its 2019 high. This data highlights the dynamic nature of cost management in the biotech sector, where strategic financial planning can lead to substantial shifts in operational efficiency.
Analyzing Cost of Revenue: Johnson & Johnson and Wave Life Sciences Ltd.
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Biogen Inc. vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: United Therapeutics Corporation and Wave Life Sciences Ltd.
Cost Insights: Breaking Down Lantheus Holdings, Inc. and Supernus Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: ADMA Biologics, Inc. vs Supernus Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Amneal Pharmaceuticals, Inc. and Wave Life Sciences Ltd.
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost of Revenue Trends: Perrigo Company plc vs Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Supernus Pharmaceuticals, Inc. and Xencor, Inc.
Cost of Revenue: Key Insights for Iovance Biotherapeutics, Inc. and Wave Life Sciences Ltd.